---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-003718"
form_type: "8-K"
ticker: "ANEB"
cik: "0001815974"
company_name: "Anebulo Pharmaceuticals, Inc."
filed_at: "2026-01-27T23:59:59+00:00"
generated_at: "2026-05-16T07:35:12.822134+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Anebulo tender offer oversubscribed; 4.9M shares tendered, 300k accepted at $3.50 per share

## Summary
- 4,897,188 shares properly tendered (excluding 10,868 by guaranteed delivery).
- Company expects to accept 300,000 shares at $3.50 each for total cost of ~$1.05M.
- Proration factor approximately 3.51542%; odd lots accepted in full.
- Shares accepted represent about 0.73% of outstanding as of Jan 26, 2026.

## SEC filing metadata
- accession: 0001493152-26-003718
- form_type: 8-K
- ticker: ANEB
- cik: 0001815974
- company_name: Anebulo Pharmaceuticals, Inc.
- filed_at: 2026-01-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815974/000149315226003718/0001493152-26-003718-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815974/000149315226003718/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-003718
- JSON: https://secwatch.observer/filing/0001493152-26-003718.json
- Plain text: https://secwatch.observer/filing/0001493152-26-003718.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.